SRX13130194 Blood-5 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064158 Blood-5 Blood-5 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130195 Brain-7 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064159 Brain-7 Brain-7 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130196 Blood-4 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064157 Blood-4 Blood-4 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130197 Brain-3 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064160 Brain-3 Brain-3 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130198 Brain-5 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064161 Brain-5 Brain-5 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130199 Blood-3 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064162 Blood-3 Blood-3 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130200 Blood-6 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064163 Blood-6 Blood-6 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130201 Blood-2 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064164 Blood-2 Blood-2 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130202 Blood-7 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064165 Blood-7 Blood-7 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130203 Brain-4 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064166 Brain-4 Brain-4 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130204 Brain-2 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064167 Brain-2 Brain-2 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130205 Blood-8 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064168 Blood-8 Blood-8 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130206 Brain-1 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064169 Brain-1 Brain-1 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130207 Brain-6 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064170 Brain-6 Brain-6 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130208 Blood-1 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064171 Blood-1 Blood-1 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000 SRX13130209 Brain-8 SRP345921 bp0 Ribosomal RNAs were depleted with Ribo-off rRNA depletion kit (Vazyme, N406-01). The purified RNA was treated with RQ1 DNase (Promega, M610A) to remove DNA before preparing the directional RNA-seq library by KAPA Stranded mRNA-Seq Kit for Illumina Platforms (Roche, KK8544). Polyadenylated mRNAs were purified and Fragmented. Fragmented mRNAs were converted into double stranded cDNA. Following end repair and A tailing, the DNAs were ligated to Diluted Roche Adaptor. After purification of ligation product and amplification, the size fraction of 300-500 nt, was purified, quantified and stored at -80 before sequencing. SRS11064172 Brain-8 Brain-8 RNA-Seq GENOMIC PCR Illumina NovaSeq 6000